Buy Sagility; target of Rs 55: Emkay Global Financial

Moneycontrol • 5 days ago

Original source

Key Investment Pillars

  • Sagility's acquisition of Chirok Health strengthens its footprint in the provider segment, adding mid-cycle expertise in clinical documentation and coding.
  • The company's deal pipeline includes more managed services opportunities with Blues and midmarket health plans, which typically involve longer sales cycles but foster deeper client relationships.
  • Sagility is progressively moving from narrow AI use cases toward end-to-end workflow transformation through agentic AI solutions.
  • The company's Synchrony AI capabilities are expected to strengthen its ability to win larger deals, while enabling the extension of its services into the mid-cycle.

Thesis Validation Checklist

  • Investors should watch for the successful integration of Chirok Health and the realization of revenue synergies.
  • The company's ability to ramp up its Synchrony AI capabilities and expand its services into the mid-cycle will be crucial.
  • The growth of the deal pipeline, particularly in managed services, will be an important indicator of the company's success.
  • The company's margin expansion and ability to maintain its disciplined cost management will be key to sustaining its growth momentum.